β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage
Clinical Science · 2023
DOI: 10.1042/cs20230313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2023. Verfasst von Marharyta Semenikhina und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, U.S.A. Hauptthemen laut MEDLINE: Podocytes, Kidney Diseases, Hypertension. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: CSRD VA, NHLBI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Angiotensin receptor blockers (ARBs) are the first-line treatment for hypertension; they act by inhibiting signaling through the angiotensin 1 receptor (AT1R). Recently, a novel biased AT1R agonist, TRV120027 (TRV), which selectively activates the β-arrestin cascade and blocks the G-protein-coupled receptor pathway has been proposed as a potential blood pressure medication. Here, we explored the effects of TRV and associated β-arrestin signaling in podocytes, essential cells of the kidney filter. We used human podocyte cell lines to determine β-arrestin’s involvement in calcium signaling and cytoskeletal reorganization and Dahl SS rats to investigate the chronic effects of TRV administration on glomerular health. Our experiments indicate that the TRV-activated β-arrestin pathway promotes the rapid elevation of intracellular Ca2+ in a dose-dependent manner. Interestingly, the amplitude of β-arrestin-mediated Ca2+ influx was significantly higher than the response to similar Ang II concentrations. Single-channel analyses show rapid activation of transient receptor potential canonical (TRPC) channels following acute TRV application. Furthermore, the pharmacological blockade of TRPC6 significantly attenuated the β-arrestin-mediated Ca2+ influx. Additionally, prolonged activation of the β-arrestin pathway in podocytes resulted in pathological actin cytoskeleton rearrangements, higher apoptotic cell markers, and augmented glomerular damage. TRV-activated β-arrestin signaling in podocytes may promote TRPC6 channel-mediated Ca2+ influx, foot process effacement, and apoptosis, possibly leading to severe defects in glomerular filtration barrier integrity and kidney health. Under these circumstances, the potential therapeutic application of TRV for hypertension treatment requires further investigation to assess the balance of the benefits versus possible deleterious effects and off-target damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, U.S.A.
- Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, U.S.A.
- Hypertension and Kidney Research Center, University of South Florida, Tampa, FL, U.S.A.
- Department of Physiology, Medical College of Georgia, Augusta University, GA, U.S.A.
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, GA, U.S.A.
- Division of Nephrology, Department of Internal Medicine, Duke University School of Medicine, Durham, NC, U.S.A.
ORCID-Profile: Daria V Ilatovskaya, Oleg Palygin
Förderung
- CSRD VA
- NHLBI NIH HHS
- BLRD VA
- NIDDK NIH HHS
- NIA NIH HHS
- Augusta University
- Division of Diabetes, Endocrinology, and Metabolic Diseases
- National Heart, Lung, and Blood Institute
Zitieren
APA
Semenikhina, M., Fedoriuk, M., Stefanenko, M., Klemens, C. A., Cherezova, A., Marshall, B., Hall, G., Levchenko, V., Solanki, A. K., Lipschutz, J. H., Ilatovskaya, D. V., Staruschenko, A., & Palygin, O. (2023). β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage. Clinical Science. https://doi.org/10.1042/cs20230313
Vancouver
Semenikhina M, Fedoriuk M, Stefanenko M, Klemens CA, Cherezova A, Marshall B, et al. β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage. Clinical Science. 2023. doi:10.1042/cs20230313
BibTeX
@article{Semenikhina2023,
author = {Semenikhina, Marharyta and Fedoriuk, Mykhailo and Stefanenko, Mariia and Klemens, Christine A and Cherezova, Alena and Marshall, Brendan and Hall, Gentzon and Levchenko, Vladislav and Solanki, Ashish K and Lipschutz, Joshua H and Ilatovskaya, Daria V and Staruschenko, Alexander and Palygin, Oleg},
title = {β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage},
journal = {Clinical Science},
year = {2023},
doi = {10.1042/cs20230313}
}
EUVIMED